Investigation on efficacy and safety of combination treatment with imidafenacin and mirabegron in patients with overactive bladder.
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Imidafenacin (Primary) ; Mirabegron
- Indications Overactive bladder
- Focus Adverse reactions
- Acronyms EstIMate study
- 02 Sep 2016 Status changed from recruiting to completed.
- 20 Jan 2015 New trial record